On-chip three-dimensional cell culture in phaseguides improves hepatocyte functions in vitro
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
The in vitro study of liver functions and liver cell specific responses to external stimuli deals with the problem to preserve the in vivo functions of primary hepatocytes. In this study, we used the biochip OrganoPlateTM (MIMETAS) that combines different advantages for the cultivation of hepatocytes in vitro: (1) the perfusion flow is achieved without a pump allowing easy handling and placement in the incubator; (2) the phaseguides allow plating of matrix-embedded cells in lanes adjacent to the perfusion flow without physical barrier; and (3) the matrix-embedding ensures indirect contact of the cells to the flow. In order to evaluate the applicability of this biochip for the study of hepatocyte's functions, MatrigelTM-embedded HepG2 cells were cultured over three weeks in this biochip and compared to a static Matrigel culture (3D) and a monolayer culture (2D). Chip-cultured cells grew in spheroid-like structures and were characterized by the formation of bile canaliculi and a high viability over 14 days. Hepatocyte-specific physiology was achieved as determined by an increase in albumin production. Improved detoxification metabolism was demonstrated by strongly increased cytochrome P450 activity and urea production. Additionally, chip-cultured cells displayed increased sensitivity to acetaminophen. Altogether, the OrganoPlate seems to be a very useful alternative for the cultivation of hepatocytes, as their behavior was strongly improved over 2D and static 3D cultures and the results were largely comparable and partly superior to the previous reports on biochip-cultured hepatocytes. As for the low technical needs, this platform has the appearance of being highly applicable for further studies of hepatocytes' responses to external stimuli.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280
Microscale culture of human liver cells for drug development
Khetani, S. R., & Bhatia, S. N. (2008) · Nature Biotechnology · doi:10.1038/nbt1361 · Cited by 1,219
Bhatia, S. N., Balis, U. J., Yarmush, M. L., & Toner, M. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.14.1883 · Cited by 890
Wagner, I., Materne, E.-M., Brincker, S., Süßbier, U., Frädrich, C., Busek, M., Sonntag, F., Sakharov, D. A., Trushkin, E. V., Tonevitsky, A. G., et al. (2013) · Lab on a Chip · doi:10.1039/c3lc50234a · Cited by 476
Microfluidic titer plate for stratified 3D cell culture
Trietsch, S. J., Israëls, G. D., Joore, J., Hankemeier, T., & Vulto, P. (2013) · Lab on a Chip · doi:10.1039/c3lc50210d · Cited by 189
Hemodynamic flow improves rat hepatocyte morphology, function, and metabolic activity in vitro
Dash, A., Simmers, M. B., Deering, T. G., Berry, D. J., Feaver, R. E., Hastings, N. E., Pruett, T. L., LeCluyse, E. L., Blackman, B. R., & Wamhoff, B. R. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00331.2012 · Cited by 108
Research works printed but not linked: 26
- 2014, Adv. Drug Delivery Rev., 69–70, 132, 10.1016/j.addr.2014.02.011 · DOI · Paper page
- 2013, Arch. Toxicol., 87, 1581, 10.1007/s00204-013-1080-y · DOI
- 2006, Biocybern. Biomed. Eng., 26, 47
- 2011, Biochem. Eng. J., 53, 172, 10.1016/j.bej.2010.10.007 · DOI
- 2000, Tissue Eng., 6, 39, 10.1089/107632700320874 · DOI · Paper page
- 2001, Biotechnol. Bioeng., 73, 379, 10.1002/bit.1071 · DOI · Paper page
- 2010, Lab Chip, 10, 3380, 10.1039/c0lc00135j · DOI · Paper page
- 2009, Lab Chip, 9, 2026, 10.1039/b900912d · DOI · Paper page
- 2007, Biotechnol. Bioeng., 97, 1340, 10.1002/bit.21360 · DOI · Paper page
- 2011, Biomicrofluidics, 5, 22212, 10.1063/1.3580753 · DOI · Paper page
- 2014, Lab Chip, 14, 2033, 10.1039/C4LC00071D · DOI · Paper page
- 2011, Lab Chip, 11, 1596, 10.1039/c0lc00643b · DOI · Paper page
- 1989, Exp. Eye Res., 49, 751, 10.1016/S0014-4835(89)80036-3 · DOI
- 1993, Anal. Biochem., 211, 102, 10.1006/abio.1993.1239 · doi:10.1006/abio.1993.1239
- 2013, J. Pharm. Sci, 102, 3264, 10.1002/jps.23466 · DOI
- 2009, Lab Chip, 9, 232, 10.1039/B809117J · DOI · Paper page
- 2001, Cells Tissues Organs, 169, 34, 10.1159/000047858 · DOI
- 2014, Arch. Toxicol., 88, 1083, 10.1007/s00204-014-1215-9 · DOI · Paper page
- 2011, J. Bioeng. Biomed. Sci., S2, 002, 10.4172/2155-9538.S2-002 · DOI · Paper page
- 2014, Biotechnol. Bioeng., 111, 885, 10.1002/bit.25157 · DOI
- 2011, Liver Transplant., 17, 104, 10.1002/lt.22200 · DOI · Paper page
- 2014, Expert Rev. Clin. Pharmacol., 7, 341, 10.1586/17512433.2014.904744 · DOI · Paper page
- 2014, JAMA, J. Am. Med. Assoc., 311, 563, 10.1001/jama.2014.716 · DOI
- 2007, ALTEX, 24, 35
- 2011, PLoS One, 6, e21268, 10.1371/journal.pone.0021268 · DOI
- 2009, Biomaterials, 30, 5927, 10.1016/j.biomaterials.2009.07.022 · DOI
Cited by
Organ-on-a-chip devices advance to market
Zhang, B., & Radisic, M. (2017) · Lab on a Chip · doi:10.1039/c6lc01554a · Cited by 437
Kidney-on-a-Chip technology for drug-induced nephrotoxicity screening
Wilmer, M. J., Ng, C. P., Lanz, H. L., Vulto, P., Suter-Dick, L., & Masereeuw, R. (2016) · Trends in Biotechnology · doi:10.1016/j.tibtech.2015.11.001 · Cited by 354
Marx, U. (2016) · ALTEX · doi:10.14573/altex.1603161 · Cited by 295
“individually addressable microfluidic networks (Jang et al., 2015; Moreno et al., 2015; Trietsch et al., 2013).”
Mimicking liver sinusoidal structures and functions using a 3D-configured microfluidic chip
Du, Y., Li, N., Yang, H., Luo, C., Gong, Y., Tong, C., Gao, Y., Lü, S., & Long, M. (2017) · Lab on a Chip · doi:10.1039/c6lc01374k · Cited by 241
Three‐dimensional cell culture models for anticancer drug screening: Worth the effort?
Verjans, E., Doijen, J., Luyten, W., Landuyt, B., & Schoofs, L. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26052 · Cited by 212
Drug Toxicity Evaluation Based on Organ-on-a-chip Technology: A Review
Cong, Y., Han, X., Wang, Y., Chen, Z., Lu, Y., Liu, T., Wu, Z., Jin, Y., Luo, Y., & Zhang, X. (2020) · Micromachines · doi:10.3390/mi11040381 · Cited by 140
“[71] added a phase guide to a 3D perfusion chip without using a pump.”
BackgroundA critical perspective on 3D liver models for drug metabolism and toxicology studies
Serras, A. S., Rodrigues, J. S., Cipriano, M., Rodrigues, A. V., Oliveira, N. G., & Miranda, J. P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.626805 · Cited by 138
Therapy response testing of breast cancer in a 3D high-throughput perfused microfluidic platform
Lanz, H. L., Saleh, A., Kramer, B., Cairns, J., Ng, C. P., Yu, J., Trietsch, S. J., Hankemeier, T., Joore, J., Vulto, P., et al. (2017) · BMC Cancer · doi:10.1186/s12885-017-3709-3 · Cited by 135
Challenges and Opportunities in the Design of Liver-on-Chip Microdevices
Ehrlich, A., Duche, D., Ouedraogo, G., & Nahmias, Y. (2019) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-060418-052305 · Cited by 125
Human biomimetic liver microphysiology systems in drug development and precision medicine
Gough, A., Soto-Gutierrez, A., Vernetti, L., Ebrahimkhani, M. R., Stern, A. M., & Taylor, D. L. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00386-1 · Cited by 117
Foster, A. J., Chouhan, B., Regan, S. L., Rollison, H., Amberntsson, S., Andersson, L. C., Srivastava, A., Darnell, M., Cairns, J., Lazic, S. E., et al. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02427-4 · Cited by 117
In vitro grafting of hepatic spheroids and organoids on a microfluidic vascular bed
Bonanini, F., Kurek, D., Previdi, S., Nicolas, A., Hendriks, D., de Ruiter, S., Meyer, M., Clapés Cabrer, M., Dinkelberg, R., García, S. B., et al. (2022) · Angiogenesis · doi:10.1007/s10456-022-09842-9 · Cited by 112
Olgasi, C., Cucci, A., & Follenzi, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176215 · Cited by 100
“Guan et al. induced iPSCs to form hepatoblast aggregates that, after dissociation and culture in Matrigel gave rise to organoids containing both hepatocyte and cholangiocytes [126].”
MethodOrganoid microphysiological system preserves pancreatic islet function within 3D matrix
Patel, S. N., Ishahak, M., Chaimov, D., Velraj, A., LaShoto, D., Hagan, D. W., Buchwald, P., Phelps, E. A., Agarwal, A., & Stabler, C. L. (2021) · Science Advances · doi:10.1126/sciadv.aba5515 · Cited by 97
Liver–heart on chip models for drug safety
Ferrari, E., & Rasponi, M. (2021) · APL Bioengineering · doi:10.1063/5.0048986 · Cited by 53
In vitro functional models for human liver diseases and drug screening: beyond animal testing
Paradiso, A., Volpi, M., Rinoldi, C., Celikkin, N., Contessi Negrini, N., Bilgen, M., Dallera, G., Pierini, F., Costantini, M., Święszkowski, W., et al. (2023) · Biomaterials Science · doi:10.1039/d1bm01872h · Cited by 40
A Model of Hepatic Steatosis with Declined Viability and Function in a Liver-Organ-on-a-Chip
Wiriyakulsit, N., Keawsomnuk, P., Thongin, S., Ketsawatsomkron, P., & Muta, K. (2023) · Scientific Reports · doi:10.1038/s41598-023-44198-0 · Cited by 29
“Even though HepG2 cells originated from human hepatocellular carcinoma, the sizes of HepG2 cluster areas in OOCs were unchanged over 2 weeks of experimental periods 24 , suggesting suppression of HepG2 proliferation in OOC platforms.”
InfluentialRecommendations toward a human pathway-based approach to disease research
Marshall, L. J., Austin, C. P., Casey, W., Fitzpatrick, S. C., & Willett, C. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.05.038 · Cited by 28
Kong, D., Yu, S., Heegsma, J., Blokzijl, T., Qin, T., Pan, Y., Blokzijl, H., de Meijer, V. E., Duan, Y., Faber, K. N., et al. (2026) · Journal of nanobiotechnology · doi:10.1186/s12951-026-04477-0 · Cited by 4
Metadata
- Authors
- Jang, M., Neuzil, P., Volk, T., Manz, A., & Kleber, A.
- Venue
- Biomicrofluidics
- Publisher
- AIP Publishing
- Published
- 2015-05-01
- Volume
- 9
- Issue
- 3
- Pages
- 034113-034113
- ISSN
- 1932-1058 (ISSN-L)
- OpenAlex
- W1632817672
- Cited by
- 95
- References
- 6
- FWCI
- 3.77
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.